DeepAI AI Chat
Log In Sign Up

Concentration of Benefit index: A threshold-free summary metric for quantifying the capacity of covariates to yield efficient treatment rules

by   Mohsen Sadatsafavi, et al.

When data on treatment assignment, outcomes, and covariates from a randomized trial are available, a question of interest is to what extent covariates can be used to optimize treatment decisions. Statistical hypothesis testing of covariate-by-treatment interaction is ill-suited for this purpose. The application of decision theory results in treatment rules that compare the expected benefit of treatment given the patient's covariates against a treatment threshold. However, determining treatment threshold is often context-specific, and any given threshold might seem arbitrary when the overall capacity towards predicting treatment benefit is of concern. We propose the Concentration of Benefit index (Cb), a threshold-free metric that quantifies the combined performance of covariates towards finding individuals who will benefit the most from treatment. The construct of the proposed index is comparing expected treatment outcomes with and without knowledge of covariates when one of a two randomly selected patients are to be treated. We show that the resulting index can also be expressed in terms of the integrated efficiency of individualized treatment decision over the entire range of treatment thresholds. We propose parametric and semi-parametric estimators, the latter being suitable for out-of-sample validation and correction for optimism. We used data from a clinical trial to demonstrate the calculations in a step-by-step fashion, and have provided the R code for implementation ( The proposed index has intuitive and theoretically sound interpretation and can be estimated with relative ease for a wide class of regression models. Beyond the conceptual developments, various aspects of estimation and inference for such a metric need to be pursued in future research.


page 1

page 2

page 3

page 4


Novel metrics for quantifying the capacity of subgroup-defining variables to yield efficient treatment rules

A major objective of subgroup analysis in clinical trials is to explore ...

Can the potential benefit of individualizing treatment be assessed using trial summary statistics alone?

Individualizing treatment assignment can improve outcomes for diseases w...

Bayesian index models for heterogeneous treatment effects

The general idea of this article is to develop a Bayesian model with a f...

A single-index model with a surface-link for optimizing individualized dose rules

This paper focuses on the problem of modeling and estimating interaction...

The Expected Jacobian Outerproduct: Theory and Empirics

The expected gradient outerproduct (EGOP) of an unknown regression funct...